Press release
Cefepime Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028
The global cefepime market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Cefepime is a cephalosporin antibiotic used to treat certain infections caused by bacteria including pneumonia, urinary tract infection, and kidney infections. The rise in the prevalence of urinary tract infections (UTI) is anticipated to drive the growth of the global cefepime market. For instance, according to the data published by National Center for Biotechnology Center (NCBI) in 2019, UTIs are the most common outpatient infections, with a lifetime incidence of 50.0-60.0% in women. The prevalence of UTI increases with the age, and in women aged 65 is approximately double the rate seen in the female population overall. The prevalence in women over 65 years of age is approximately 20.0%, compared with approximately 11.0% of the population. Moreover, 50.0% and 60.0% of adult women are projected to have UTIs at least once in their lifetime, and close to 10.0% of postmenopausal women indicate that they had a UTI in the previous year.A full report of Cefepime Market is available at:https://orionmarketreports.com/cefepime-market/95641/
Moreover, the rise in the prevalence of pneumonia is anticipated to drive the growth of the global imipenem API market. For instance, according to the data published by World Health Organization (WHO) in 2021, pneumonia registered for 14.0% of all mortalities in children under 5 years old, and 740180 mortalities occurred in children in 2019. The WHO states that pneumonia can be protected with simple interventions, and can be treated with low cost, low tech medication, and care. Also, according to the data published by NCBI, pneumonia is the eighth leading cause of mortality and first among infectious causes of mortality. Further, pneumonia varies between 1.5 to 14 cases per 1000 people and is affected by geography, season, and population characteristics. Thus, the rise in the prevalence of pneumonia is anticipated to drive the demand for the global cefepime market.
Looking towards the demand for cefepime, key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2022, Venatrox Pharmacueticals Inc., in collaboration with GARDP had announced the positive results from its pivotal phase 3 evaluating cefepime-taniborbactum as a treatment option for hospitalized adult patients with urinary tract infection. Moreover, since April 2020, GARDP and Venatrox pharmaceutical Inc had been working to accelerate the development of cefepime and a new drug application is anticipated to be filled with USFDA in the fourth quarter of 2022. Thus, such clinical trials are anticipated to drive the growth of the global cefepime market.
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape-Pfizer Inc, Baxter International Inc, and B.Braun Melsungen AG among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Cefepime Market Report by Segment
By Type
Intramuscular Injection
Intravenous Drug Delivery
By Application
Lower Respiratory Tract Infection
Skin and Soft tissue Infection
Urinary Tract Infection
Abdominal Cavity Infection
Gynecologic Infection
Neutrophilic Fever
Sepsis
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cefepime Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028 here
News-ID: 2594551 • Views: …
More Releases from Orion Market Reports
Nanoporous Market to Witness Astonishing Growth by 2031
The Nanoporous Market size is expected to grow at an annual average of CAGR 8% during the forecast period (2024-2031).Nanoporous materials are substances that contain a network of pores with diameters typically less than 100 nanometers. These pores give the materials a high surface area and unique physical and chemical properties, making them useful in various applications such as catalysis, adsorption, filtration, and drug delivery.
Nanoporous Market research report is one…
Nanocrystal Market to see Rapid Growth by 2031
The Nanocrystal Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031).Nanocrystals are nanoscale particles that possess crystalline structures. These particles typically range in size from 1 to 100 nanometers and exhibit unique physical and chemical properties due to their small size and high surface area-to-volume ratio. Nanocrystals can be made from various materials, including metals, semiconductors, and ceramics, and they have…
Finned Tube Exchanger Market Will Generate Record Revenue by 2031
The Finned Tube Exchanger Market size is expected to grow at an annual average of CAGR 8% during the forecast period (2024-2031). A finned tube exchanger is a type of heat exchanger that uses tubes with external fins to enhance the transfer of heat between two fluids. The fins increase the surface area available for heat exchange, making the process more efficient. Finned tube exchangers are commonly used in various…
Finned Coil Heat Exchanger Market Value Projected to Expand by 2031
The Finned Coil Heat Exchanger Market size is expected to grow at an annual average of CAGR 8% during the forecast period (2024-2031). A finned coil heat exchanger is a type of heat exchanger that uses a coil of tubing surrounded by fins to enhance the transfer of heat between two fluids. The fins increase the surface area available for heat exchange, improving the efficiency of the process. These heat…
More Releases for UTI
Retail Logistics Market Worth Observing Growth | Panalpina, Exel, UTi Worldwide
The latest launched report on Global Retail Logistics Market delivers a transformation framework to understand how megatrends affect industry growth, taking into account the major disrupting forces creating uncertainties for every organisation in the Retail Logistics. Based on these outcomes, HTF MI outline plan for these volatile scenarios considering companies such as APL Logistics, Schneider National, Maersk Logistics, SembCorp Logistics (USA), Panalpina, Exel, UTi Worldwide, Kuehne + Nagel International, DHL…
Urinary Tract Infection (UTI) Treatment Market Growth, Trends, Industry Analysis …
The Global Urinary Tract Infection Treatment Market was valued at US$ 9,971.9 Mn in 2019 and is forecast to reach a value of US$ 11,827.8 Mn by 2027 at a CAGR of 2% between 2021 and 2027.
Urinary tract infection (UTI) is one of the most common health problems for most people. UTIs are more common in women than in men because women face health complications such as menopause, pregnancy, and…
Logistic Software Market Will Hit Big Revenues In Future | Oracle, UTi Worldwide …
Latest released the research study on Global Logistic Software Market, offers a detailed overview of the factors influencing the global business scope. Logistic Software Market research report shows the latest market insights; current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Logistic Software. The study covers emerging player’s data, including: competitive…
UTI Treatment Market Therapeutic Assessment 2018-2023
Global and Chinese UTI Treatment Industry, 2018 Market Research Report:
The 'Global and Chinese UTI Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global UTI Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the UTI Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals…
UTI treatment Business Trends That Will Drive Success In 2023
The Global UTI treatment Market is growing with the rapid pace; mainly due the burgeoning Healthcare Sector. According to a recent study report published by the Market Research Future, The global UTI treatment Market is booming and expected to gain prominence over the forecast period.
Global UTI treatment Market Information; by Drug Class (Quinolones, Aminoglycosides, β-lactam, Azoles and Others), by Clinical Indications (Urethritis, Cystitis, Pyelonephritis), by End User (Hospitals and Self-administered)…
Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally
Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract…
